25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ProstaLund AB
Buy, Hold or Sell?

Let's analyze Prostalund together

I guess you are interested in ProstaLund AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ProstaLund AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ProstaLund AB

I send you an email if I find something interesting about ProstaLund AB.

1. Quick Overview

1.1. Quick analysis of Prostalund (30 sec.)










1.2. What can you expect buying and holding a share of Prostalund? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.47
Expected worth in 1 year
kr0.17
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
kr-0.30
Return On Investment
-3.1%

For what price can you sell your share?

Current Price per Share
kr9.46
Expected price per share
kr6.12 - kr14.20
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Prostalund (5 min.)




Live pricePrice per Share (EOD)
kr9.46
Intrinsic Value Per Share
kr-4.55 - kr6.09
Total Value Per Share
kr-4.08 - kr6.56

2.2. Growth of Prostalund (5 min.)




Is Prostalund growing?

Current yearPrevious yearGrowGrow %
How rich?$5.1m$4.5m$94.7k2.0%

How much money is Prostalund making?

Current yearPrevious yearGrowGrow %
Making money-$445k-$375.7k-$69.2k-15.6%
Net Profit Margin-143.6%-80.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Prostalund (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Prostalund?

Welcome investor! Prostalund's management wants to use your money to grow the business. In return you get a share of Prostalund.

First you should know what it really means to hold a share of Prostalund. And how you can make/lose money.

Speculation

The Price per Share of Prostalund is kr9.46. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Prostalund.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Prostalund, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.47. Based on the TTM, the Book Value Change Per Share is kr-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Prostalund.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.000.0%-0.01-0.1%-0.01-0.1%-0.01-0.1%-0.01-0.2%
Usd Book Value Change Per Share-0.01-0.1%-0.01-0.1%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.1%-0.01-0.1%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.04-0.08-0.26-0.27-0.39-
Price to Earnings Ratio-2.73--4.27--12.21--15.89--10.85-
Price-to-Total Gains Ratio-4.20--15.29--24.54--35.74--26.78-
Price to Book Ratio0.85-1.37-3.94-4.72-4.23-
Price-to-Total Gains Ratio-4.20--15.29--24.54--35.74--26.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.848562
Number of shares1178
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (1178 shares)-7.81-2.05
Gains per Year (1178 shares)-31.25-8.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-31-410-8-18
20-63-720-16-26
30-94-1030-25-34
40-125-1340-33-42
50-156-1650-41-50
60-188-1960-49-58
70-219-2270-57-66
80-250-2580-66-74
90-281-2890-74-82
100-313-3200-82-90

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%1.048.00.02.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%9.031.00.022.5%12.036.01.024.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.049.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%9.031.00.022.5%12.036.01.024.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ProstaLund AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.095-0.074-22%-0.020-79%-0.019-80%-0.040-58%
Book Value Per Share--0.4710.604-22%0.790-40%0.658-28%1.153-59%
Current Ratio--4.9693.898+27%3.800+31%3.461+44%3.963+25%
Debt To Asset Ratio--0.1050.151-30%0.167-37%0.179-41%0.194-46%
Debt To Equity Ratio--0.1170.181-35%0.201-42%0.222-47%0.251-53%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--54429176.76372172242.840-25%193208225.482-72%156759677.769-65%110977878.359-51%
Eps---0.036-0.059+62%-0.064+76%-0.058+59%-0.164+351%
Ev To Ebitda Ratio---3.065-4.411+44%-12.938+322%-16.477+438%-11.376+271%
Ev To Sales Ratio--3.9324.278-8%9.074-57%9.786-60%7.386-47%
Free Cash Flow Per Share---0.052-0.087+66%-0.087+67%-0.089+70%-0.192+266%
Free Cash Flow To Equity Per Share--0.071-0.045+163%0.032+125%-0.006+109%0.010+604%
Gross Profit Margin--1.7141.763-3%2.167-21%2.214-23%2.185-22%
Intrinsic Value_10Y_max--6.091--------
Intrinsic Value_10Y_min---4.554--------
Intrinsic Value_1Y_max---0.221--------
Intrinsic Value_1Y_min---0.719--------
Intrinsic Value_3Y_max---0.030--------
Intrinsic Value_3Y_min---1.945--------
Intrinsic Value_5Y_max--0.925--------
Intrinsic Value_5Y_min---2.927--------
Market Cap34283513.000-43%49092176.76371782492.840-32%184406975.482-73%153212727.769-68%107186553.359-54%
Net Profit Margin---1.297-1.436+11%-0.804-38%-0.885-32%-0.918-29%
Operating Margin---1.284-1.429+11%-0.796-38%-0.880-31%-0.924-28%
Operating Ratio--2.2842.468-7%1.798+27%1.886+21%1.915+19%
Pb Ratio20.101+96%0.8481.372-38%3.943-78%4.724-82%4.233-80%
Pe Ratio-64.822-2271%-2.734-4.271+56%-12.208+347%-15.894+481%-10.851+297%
Price Per Share9.460+96%0.3990.877-54%2.952-86%2.997-87%4.403-91%
Price To Free Cash Flow Ratio-45.100-2271%-1.902-2.456+29%-12.963+581%23.079-108%10.538-118%
Price To Total Gains Ratio-99.583-2271%-4.200-15.292+264%-24.537+484%-35.735+751%-26.777+538%
Quick Ratio--1.9711.482+33%2.205-11%1.945+1%2.286-14%
Return On Assets---0.069-0.083+20%-0.069-1%-0.075+8%-0.108+55%
Return On Equity---0.078-0.100+29%-0.083+7%-0.092+18%-0.138+78%
Total Gains Per Share---0.095-0.074-22%-0.020-79%-0.019-80%-0.040-58%
Usd Book Value--5194168.2004641033.150+12%4546265.100+14%3346370.625+55%2499820.148+108%
Usd Book Value Change Per Share---0.009-0.007-22%-0.002-79%-0.002-80%-0.004-58%
Usd Book Value Per Share--0.0420.054-22%0.071-40%0.059-28%0.103-59%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--4882297.1566473850.183-25%17330777.826-72%14061343.096-65%9954715.689-51%
Usd Eps---0.003-0.005+62%-0.006+76%-0.005+59%-0.015+351%
Usd Free Cash Flow---578744.400-654025.125+13%-526269.900-9%-448625.580-22%-370463.243-36%
Usd Free Cash Flow Per Share---0.005-0.008+66%-0.008+67%-0.008+70%-0.017+266%
Usd Free Cash Flow To Equity Per Share--0.006-0.004+163%0.003+125%-0.001+109%0.001+604%
Usd Market Cap3075231.116-43%4403568.2566438889.608-32%16541305.701-73%13743181.681-68%9614633.836-54%
Usd Price Per Share0.849+96%0.0360.079-54%0.265-86%0.269-87%0.395-91%
Usd Profit---402663.300-445001.700+11%-375730.875-7%-290749.095-28%-282559.485-30%
Usd Revenue--310451.700363711.075-15%477966.450-35%369214.170-16%336529.733-8%
Usd Total Gains Per Share---0.009-0.007-22%-0.002-79%-0.002-80%-0.004-58%
 EOD+3 -5MRQTTM+22 -16YOY+15 -235Y+18 -2010Y+17 -21

3.3 Fundamental Score

Let's check the fundamental score of ProstaLund AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-64.822
Price to Book Ratio (EOD)Between0-120.101
Net Profit Margin (MRQ)Greater than0-1.297
Operating Margin (MRQ)Greater than0-1.284
Quick Ratio (MRQ)Greater than11.971
Current Ratio (MRQ)Greater than14.969
Debt to Asset Ratio (MRQ)Less than10.105
Debt to Equity Ratio (MRQ)Less than10.117
Return on Equity (MRQ)Greater than0.15-0.078
Return on Assets (MRQ)Greater than0.05-0.069
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of ProstaLund AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose9.500
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About ProstaLund AB

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.

Fundamental data was last updated by Penke on 2025-01-16 20:31:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Prostalund earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Prostalund to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -129.7% means that kr-1.30 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ProstaLund AB:

  • The MRQ is -129.7%. The company is making a huge loss. -2
  • The TTM is -143.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-129.7%TTM-143.6%+13.9%
TTM-143.6%YOY-80.4%-63.2%
TTM-143.6%5Y-88.5%-55.0%
5Y-88.5%10Y-91.8%+3.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-129.7%4.5%-134.2%
TTM-143.6%3.4%-147.0%
YOY-80.4%2.7%-83.1%
5Y-88.5%3.2%-91.7%
10Y-91.8%3.7%-95.5%
4.3.1.2. Return on Assets

Shows how efficient Prostalund is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Prostalund to the Medical Care Facilities industry mean.
  • -6.9% Return on Assets means that Prostalund generated kr-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ProstaLund AB:

  • The MRQ is -6.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.9%TTM-8.3%+1.4%
TTM-8.3%YOY-6.9%-1.4%
TTM-8.3%5Y-7.5%-0.9%
5Y-7.5%10Y-10.8%+3.3%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.9%1.6%-8.5%
TTM-8.3%1.3%-9.6%
YOY-6.9%0.9%-7.8%
5Y-7.5%1.2%-8.7%
10Y-10.8%1.1%-11.9%
4.3.1.3. Return on Equity

Shows how efficient Prostalund is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Prostalund to the Medical Care Facilities industry mean.
  • -7.8% Return on Equity means Prostalund generated kr-0.08 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ProstaLund AB:

  • The MRQ is -7.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.8%TTM-10.0%+2.2%
TTM-10.0%YOY-8.3%-1.7%
TTM-10.0%5Y-9.2%-0.8%
5Y-9.2%10Y-13.8%+4.6%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.8%3.6%-11.4%
TTM-10.0%3.1%-13.1%
YOY-8.3%2.3%-10.6%
5Y-9.2%2.9%-12.1%
10Y-13.8%3.1%-16.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ProstaLund AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Prostalund is operating .

  • Measures how much profit Prostalund makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Prostalund to the Medical Care Facilities industry mean.
  • An Operating Margin of -128.4% means the company generated kr-1.28  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ProstaLund AB:

  • The MRQ is -128.4%. The company is operating very inefficient. -2
  • The TTM is -142.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-128.4%TTM-142.9%+14.5%
TTM-142.9%YOY-79.6%-63.3%
TTM-142.9%5Y-88.0%-54.9%
5Y-88.0%10Y-92.4%+4.4%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.4%8.2%-136.6%
TTM-142.9%6.8%-149.7%
YOY-79.6%8.3%-87.9%
5Y-88.0%6.9%-94.9%
10Y-92.4%7.8%-100.2%
4.3.2.2. Operating Ratio

Measures how efficient Prostalund is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 2.28 means that the operating costs are kr2.28 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of ProstaLund AB:

  • The MRQ is 2.284. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.468. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.284TTM2.468-0.184
TTM2.468YOY1.798+0.670
TTM2.4685Y1.886+0.582
5Y1.88610Y1.915-0.029
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2841.000+1.284
TTM2.4681.014+1.454
YOY1.7980.982+0.816
5Y1.8860.989+0.897
10Y1.9150.977+0.938
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ProstaLund AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Prostalund is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 4.97 means the company has kr4.97 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of ProstaLund AB:

  • The MRQ is 4.969. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.898. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.969TTM3.898+1.070
TTM3.898YOY3.800+0.098
TTM3.8985Y3.461+0.438
5Y3.46110Y3.963-0.502
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9691.255+3.714
TTM3.8981.251+2.647
YOY3.8001.316+2.484
5Y3.4611.386+2.075
10Y3.9631.463+2.500
4.4.3.2. Quick Ratio

Measures if Prostalund is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Prostalund to the Medical Care Facilities industry mean.
  • A Quick Ratio of 1.97 means the company can pay off kr1.97 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ProstaLund AB:

  • The MRQ is 1.971. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.482. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.971TTM1.482+0.489
TTM1.482YOY2.205-0.723
TTM1.4825Y1.945-0.463
5Y1.94510Y2.286-0.341
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9710.841+1.130
TTM1.4820.839+0.643
YOY2.2051.027+1.178
5Y1.9451.179+0.766
10Y2.2861.190+1.096
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ProstaLund AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Prostalund assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Prostalund to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.10 means that Prostalund assets are financed with 10.5% credit (debt) and the remaining percentage (100% - 10.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ProstaLund AB:

  • The MRQ is 0.105. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.151. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.151-0.046
TTM0.151YOY0.167-0.016
TTM0.1515Y0.179-0.028
5Y0.17910Y0.194-0.015
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1050.518-0.413
TTM0.1510.522-0.371
YOY0.1670.521-0.354
5Y0.1790.545-0.366
10Y0.1940.528-0.334
4.5.4.2. Debt to Equity Ratio

Measures if Prostalund is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Prostalund to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 11.7% means that company has kr0.12 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ProstaLund AB:

  • The MRQ is 0.117. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.181. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.181-0.064
TTM0.181YOY0.201-0.020
TTM0.1815Y0.222-0.041
5Y0.22210Y0.251-0.029
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1170.950-0.833
TTM0.1810.975-0.794
YOY0.2010.996-0.795
5Y0.2221.153-0.931
10Y0.2511.238-0.987
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Prostalund generates.

  • Above 15 is considered overpriced but always compare Prostalund to the Medical Care Facilities industry mean.
  • A PE ratio of -2.73 means the investor is paying kr-2.73 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ProstaLund AB:

  • The EOD is -64.822. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.734. Based on the earnings, the company is expensive. -2
  • The TTM is -4.271. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-64.822MRQ-2.734-62.088
MRQ-2.734TTM-4.271+1.537
TTM-4.271YOY-12.208+7.937
TTM-4.2715Y-15.894+11.624
5Y-15.89410Y-10.851-5.043
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-64.82213.457-78.279
MRQ-2.73413.190-15.924
TTM-4.27114.646-18.917
YOY-12.20814.491-26.699
5Y-15.89417.408-33.302
10Y-10.85122.593-33.444
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ProstaLund AB:

  • The EOD is -45.100. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.902. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.456. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-45.100MRQ-1.902-43.198
MRQ-1.902TTM-2.456+0.554
TTM-2.456YOY-12.963+10.507
TTM-2.4565Y23.079-25.535
5Y23.07910Y10.538+12.541
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-45.1008.929-54.029
MRQ-1.9029.764-11.666
TTM-2.4568.213-10.669
YOY-12.9637.427-20.390
5Y23.0797.329+15.750
10Y10.5387.007+3.531
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Prostalund is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.85 means the investor is paying kr0.85 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of ProstaLund AB:

  • The EOD is 20.101. Based on the equity, the company is expensive. -2
  • The MRQ is 0.848. Based on the equity, the company is cheap. +2
  • The TTM is 1.372. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.101MRQ0.848+19.253
MRQ0.848TTM1.372-0.524
TTM1.372YOY3.943-2.571
TTM1.3725Y4.724-3.353
5Y4.72410Y4.233+0.491
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD20.1011.744+18.357
MRQ0.8481.903-1.055
TTM1.3721.944-0.572
YOY3.9432.167+1.776
5Y4.7242.357+2.367
10Y4.2332.710+1.523
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets64,690
Total Liabilities6,784
Total Stockholder Equity57,906
 As reported
Total Liabilities 6,784
Total Stockholder Equity+ 57,906
Total Assets = 64,690

Assets

Total Assets64,690
Total Current Assets30,562
Long-term Assets34,128
Total Current Assets
Cash And Cash Equivalents 12,121
Inventory 14,564
Other Current Assets 3,877
Total Current Assets  (as reported)30,562
Total Current Assets  (calculated)30,562
+/-0
Long-term Assets
Property Plant Equipment 854
Long-term Assets  (as reported)34,128
Long-term Assets  (calculated)854
+/- 33,274

Liabilities & Shareholders' Equity

Total Current Liabilities6,151
Long-term Liabilities633
Total Stockholder Equity57,906
Total Current Liabilities
Short-term Debt 400
Accounts payable 4,552
Other Current Liabilities 1,199
Total Current Liabilities  (as reported)6,151
Total Current Liabilities  (calculated)6,151
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)633
Long-term Liabilities  (calculated)0
+/- 633
Total Stockholder Equity
Other Stockholders Equity 57,906
Total Stockholder Equity (as reported)57,906
Total Stockholder Equity (calculated)57,906
+/-0
Other
Cash and Short Term Investments 12,121
Common Stock Shares Outstanding 123,038
Liabilities and Stockholders Equity 64,690
Net Debt -11,088
Net Working Capital 24,411
Short Long Term Debt Total 1,033



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
0
6,914
0
8,312
7,482
9,611
7,905
20,081
17,744
15,856
13,111
11,208
29,614
27,102
23,539
20,689
18,641
35,232
31,588
26,568
23,839
17,924
26,047
21,770
19,991
19,156
16,832
30,304
29,010
26,389
26,880
21,799
33,092
30,837
30,085
26,526
42,984
43,480
42,280
38,386
52,272
51,043
45,651
78,011
68,716
65,507
57,182
55,815
64,690
64,69055,81557,18265,50768,71678,01145,65151,04352,27238,38642,28043,48042,98426,52630,08530,83733,09221,79926,88026,38929,01030,30416,83219,15619,99121,77026,04717,92423,83926,56831,58835,23218,64120,68923,53927,10229,61411,20813,11115,85617,74420,0817,9059,6117,4828,31206,9140
   > Total Current Assets 
0
3,931
737
5,272
5,049
7,190
5,391
17,584
15,250
13,292
10,417
8,606
26,993
24,073
20,373
17,382
15,153
31,574
27,389
21,737
19,184
12,115
19,750
15,111
13,361
12,412
9,977
23,074
21,435
17,750
16,926
10,745
21,419
18,897
15,614
10,446
25,918
22,660
18,360
13,606
27,218
25,690
20,043
51,651
41,863
37,074
26,998
24,252
30,562
30,56224,25226,99837,07441,86351,65120,04325,69027,21813,60618,36022,66025,91810,44615,61418,89721,41910,74516,92617,75021,43523,0749,97712,41213,36115,11119,75012,11519,18421,73727,38931,57415,15317,38220,37324,07326,9938,60610,41713,29215,25017,5845,3917,1905,0495,2727373,9310
       Cash And Cash Equivalents 
0
737
-737
445
271
2,292
1,129
12,512
8,383
5,966
2,989
956
19,114
16,110
11,151
7,251
3,971
20,672
16,241
10,220
5,251
1,584
9,042
4,155
1,479
2,886
3,087
14,440
13,548
9,760
9,713
2,991
13,295
10,495
5,566
2,761
16,703
13,239
7,913
4,373
15,941
12,275
6,349
34,390
22,880
15,350
6,944
3,380
12,121
12,1213,3806,94415,35022,88034,3906,34912,27515,9414,3737,91313,23916,7032,7615,56610,49513,2952,9919,7139,76013,54814,4403,0872,8861,4794,1559,0421,5845,25110,22016,24120,6723,9717,25111,15116,11019,1149562,9895,9668,38312,5121,1292,292271445-7377370
       Short-term Investments 
0
0
1,474
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000001,47400
       Net Receivables 
0
912
0
2,401
1,572
1,392
1,186
1,383
2,652
1,581
1,842
2,334
3,084
2,378
2,485
3,088
3,357
2,953
3,397
3,469
-920
2,326
2,587
2,492
3,595
1,963
230
867
1,477
1,645
931
1,069
1,872
2,198
4,245
1,507
2,650
1,355
2,883
1,778
2,653
2,816
1,541
1,527
2,734
3,530
2,097
1,233
0
01,2332,0973,5302,7341,5271,5412,8162,6531,7782,8831,3552,6501,5074,2452,1981,8721,0699311,6451,4778672301,9633,5952,4922,5872,326-9203,4693,3972,9533,3573,0882,4852,3783,0842,3341,8421,5812,6521,3831,1861,3921,5722,40109120
       Other Current Assets 
0
612
0
1,198
1,261
1,561
712
1,122
667
921
706
447
378
716
1,178
811
987
1,321
915
1,162
6,634
937
1,078
1,007
781
843
402
1,662
724
1,350
944
1,346
970
961
901
1,147
527
1,496
1,519
1,034
780
2,833
1,115
1,986
1,577
2,509
2,000
4,347
3,877
3,8774,3472,0002,5091,5771,9861,1152,8337801,0341,5191,4965271,1479019619701,3469441,3507241,6624028437811,0071,0789376,6341,1629151,3219878111,1787163784477069216671,1227121,5611,2611,19806120
   > Long-term Assets 
0
1,548
-737
3,040
2,433
2,421
2,514
2,497
2,494
2,564
2,694
2,602
2,621
3,029
3,166
3,307
3,488
3,658
4,198
4,831
5,575
5,809
6,297
6,659
6,630
6,744
6,855
7,230
7,575
8,639
9,954
11,054
11,673
11,940
14,471
16,080
17,066
20,820
23,920
24,780
25,054
25,353
25,608
26,360
26,853
28,433
30,184
31,563
34,128
34,12831,56330,18428,43326,85326,36025,60825,35325,05424,78023,92020,82017,06616,08014,47111,94011,67311,0549,9548,6397,5757,2306,8556,7446,6306,6596,2975,8095,5754,8314,1983,6583,4883,3073,1663,0292,6212,6022,6942,5642,4942,4972,5142,4212,4333,040-7371,5480
       Property Plant Equipment 
0
354
0
314
309
338
317
296
277
220
198
181
316
487
605
667
731
839
695
551
424
303
265
229
185
151
83
69
55
43
29
15
6
305
417
395
425
400
425
395
366
419
381
445
431
396
346
398
854
854398346396431445381419366395425400425395417305615294355698315118522926530342455169583973166760548731618119822027729631733830931403540
       Goodwill 
0
1,194
0
1,059
992
924
857
791
722
750
679
609
536
464
394
323
256
178
109
62
62
62
62
62
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000062626262621091782563233944645366096797507227918579249921,05901,1940
       Intangible Assets 
0
0
0
0
0
1,150
1,338
1,405
1,488
1,585
1,817
1,812
1,769
2,078
2,167
2,317
2,501
2,641
3,393
4,218
5,089
5,443
5,970
6,368
6,445
6,593
0
0
0
8,596
0
0
0
11,635
0
0
0
20,420
0
0
0
24,933
0
0
26,422
28,037
0
30,701
0
030,701028,03726,4220024,93300020,42000011,6350008,5960006,5936,4456,3685,9705,4435,0894,2183,3932,6412,5012,3172,1672,0781,7691,8121,8171,5851,4881,4051,3381,15000000
       Other Assets 
0
1,435
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
-920
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000-9200100000000000000001,4350
> Total Liabilities 
0
1,658
0
3,688
3,978
4,377
4,385
3,366
3,799
3,970
3,006
4,076
4,433
3,909
3,613
3,716
3,717
4,421
4,110
4,743
3,643
4,149
4,408
3,795
3,330
6,445
6,961
8,623
4,331
4,157
6,653
4,312
4,560
5,485
6,731
5,613
6,075
8,024
9,303
10,587
7,075
9,357
7,191
14,121
10,020
10,216
6,742
12,494
6,784
6,78412,4946,74210,21610,02014,1217,1919,3577,07510,5879,3038,0246,0755,6136,7315,4854,5604,3126,6534,1574,3318,6236,9616,4453,3303,7954,4084,1493,6434,7434,1104,4213,7173,7163,6133,9094,4334,0763,0063,9703,7993,3664,3854,3773,9783,68801,6580
   > Total Current Liabilities 
0
1,658
0
3,688
3,978
4,377
4,385
3,366
3,799
3,970
2,993
4,063
4,420
3,896
3,600
3,703
3,704
4,408
4,096
4,730
3,630
4,149
4,408
3,795
3,330
5,645
6,161
7,823
2,770
3,756
6,320
3,979
4,260
5,285
6,631
5,513
5,975
8,024
9,303
9,054
5,642
8,024
5,958
12,988
8,987
9,283
5,909
11,761
6,151
6,15111,7615,9099,2838,98712,9885,9588,0245,6429,0549,3038,0245,9755,5136,6315,2854,2603,9796,3203,7562,7707,8236,1615,6453,3303,7954,4084,1493,6304,7304,0964,4083,7043,7033,6003,8964,4204,0632,9933,9703,7993,3664,3854,3773,9783,68801,6580
       Short-term Debt 
0
0
0
0
0
1,000
0
0
0
103
0
0
0
325
0
0
0
227
0
0
0
0
0
0
26
1,915
1,915
200
400
400
400
400
400
-217
400
300
200
-1,168
3,100
3,400
400
400
400
400
400
214
490
4,430
400
4004,4304902144004004004004003,4003,100-1,168200300400-2174004004004004002001,9151,915260000002270003250001030001,00000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
400
400
400
490
4,430
0
04,430490400400400400000000000000000000000000000000000000000000
       Accounts payable 
0
1,149
0
1,113
1,549
2,081
1,808
1,954
2,718
1,918
677
1,753
2,360
2,047
1,414
1,484
1,607
1,877
2,158
2,191
1,662
1,984
2,285
1,723
1,756
1,739
1,723
5,759
2,370
2,007
3,405
927
2,676
2,808
2,831
2,878
3,528
6,144
4,365
2,449
4,023
6,130
4,099
10,859
5,538
6,240
3,859
5,961
4,552
4,5525,9613,8596,2405,53810,8594,0996,1304,0232,4494,3656,1443,5282,8782,8312,8082,6769273,4052,0072,3705,7591,7231,7391,7561,7232,2851,9841,6622,1912,1581,8771,6071,4841,4142,0472,3601,7536771,9182,7181,9541,8082,0811,5491,11301,1490
       Other Current Liabilities 
0
509
0
2,575
2,429
1,220
2,486
1,230
990
1,622
2,251
2,121
1,912
1,672
2,110
2,117
1,847
1,996
1,938
2,527
1,858
2,165
2,123
2,072
1,548
3,851
2,523
1,864
1,061
1,349
2,515
2,652
1,184
254
3,400
2,335
2,247
232
1,838
3,205
1,219
1,301
1,459
1,729
3,049
2,457
1,560
1,370
1,199
1,1991,3701,5602,4573,0491,7291,4591,3011,2193,2051,8382322,2472,3353,4002541,1842,6522,5151,3491,0611,8642,5233,8511,5482,0722,1232,1651,8582,5271,9381,9961,8472,1172,1101,6721,9122,1212,2511,6229901,2302,4861,2202,4292,57505090
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
13
13
13
13
13
13
13
13
14
13
13
0
0
0
0
800
800
800
1,561
401
333
333
300
200
100
100
100
0
7,465
1,533
1,433
1,333
1,233
1,133
1,033
933
833
733
633
6337338339331,0331,1331,2331,3331,4331,5337,46501001001002003003333334011,561800800800000013131413131313131313130000000000
> Total Stockholder Equity
0
4,690
4,690
4,624
2,583
5,234
3,520
16,715
13,945
11,886
10,105
7,132
25,181
23,193
19,926
16,973
14,924
30,811
27,478
21,825
20,196
13,774
21,639
17,975
16,661
12,711
9,871
21,681
24,679
22,233
20,227
17,487
28,532
25,352
23,354
20,913
36,909
35,456
32,977
27,799
45,197
41,686
38,460
63,890
58,696
55,291
50,530
43,321
57,906
57,90643,32150,53055,29158,69663,89038,46041,68645,19727,79932,97735,45636,90920,91323,35425,35228,53217,48720,22722,23324,67921,6819,87112,71116,66117,97521,63913,77420,19621,82527,47830,81114,92416,97319,92623,19325,1817,13210,10511,88613,94516,7153,5205,2342,5834,6244,6904,6900
   Common Stock
0
2,439
0
2,439
2,606
3,185
3,185
3,185
4,777
4,816
4,816
4,816
6,421
6,421
6,421
6,421
6,421
10,274
10,274
10,274
10,274
10,274
13,698
13,698
16,661
13,698
9,871
21,681
24,679
32,525
20,227
17,487
28,532
42,157
23,354
20,913
36,909
51,525
32,977
27,799
45,197
5,719
38,460
63,890
58,696
7,659
50,530
43,321
0
043,32150,5307,65958,69663,89038,4605,71945,19727,79932,97751,52536,90920,91323,35442,15728,53217,48720,22732,52524,67921,6819,87113,69816,66113,69813,69810,27410,27410,27410,27410,2746,4216,4216,4216,4216,4214,8164,8164,8164,7773,1853,1853,1852,6062,43902,4390
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
4,690
0
0
5
15
-111
-76
-296
-391
-215
-284
-172
145
-141
-270
-22,365
121
778
1,310
-143
171
-158
0
157
0
0
0
12
0
0
0
141
0
0
0
-92,635
0
0
0
-104,864
0
0
0
-1,143
0
0
0
000-1,143000-104,864000-92,635000141000120001570-158171-1431,310778121-22,365-270-141145-172-284-215-391-296-76-111155004,69000
   Capital Surplus 0000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
3
0
3,014
0
6,689
2,049
-111
-76
20,358
-391
-215
-284
39,309
0
-141
16,502
54,876
20,537
20,537
20,537
54,733
0
-158
16,661
0
0
21,681
24,679
1
20,227
17,487
28,532
67,799
23,354
20,913
36,909
169,195
0
27,799
45,197
245,695
0
0
0
169,512
0
0
57,906
57,90600169,512000245,69545,19727,7990169,19536,90920,91323,35467,79928,53217,48720,227124,67921,6810016,661-158054,73320,53720,53720,53754,87616,502-141039,309-284-215-39120,358-76-1112,0496,68903,014030



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,206
Cost of Revenue-6,554
Gross Profit15,65215,652
 
Operating Income (+$)
Gross Profit15,652
Operating Expense-32,503
Operating Income-16,851-16,851
 
Operating Expense (+$)
Research Development5,019
Selling General Administrative9,316
Selling And Marketing Expenses17,889
Operating Expense32,50332,224
 
Net Interest Income (+$)
Interest Income14
Interest Expense-173
Other Finance Cost-0
Net Interest Income-159
 
Pretax Income (+$)
Operating Income-16,851
Net Interest Income-159
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,010-16,692
EBIT - interestExpense = -17,010
-17,010
-16,837
Interest Expense173
Earnings Before Interest and Taxes (EBIT)-16,837-16,837
Earnings Before Interest and Taxes (EBITDA)-16,572
 
After tax Income (+$)
Income Before Tax-17,010
Tax Provision-0
Net Income From Continuing Ops-17,010-17,010
Net Income-17,010
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses39,057
Total Other Income/Expenses Net-159159
 

Technical Analysis of Prostalund
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Prostalund. The general trend of Prostalund is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Prostalund's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ProstaLund AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.40 < 11.88 < 14.20.

The bearish price targets are: 6.8 > 6.12.

Tweet this
ProstaLund AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ProstaLund AB. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ProstaLund AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ProstaLund AB.

ProstaLund AB Daily Moving Average Convergence/Divergence (MACD) ChartProstaLund AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ProstaLund AB. The current adx is .

ProstaLund AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ProstaLund AB.

ProstaLund AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ProstaLund AB.

ProstaLund AB Daily Relative Strength Index (RSI) ChartProstaLund AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ProstaLund AB.

ProstaLund AB Daily Stochastic Oscillator ChartProstaLund AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ProstaLund AB.

ProstaLund AB Daily Commodity Channel Index (CCI) ChartProstaLund AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ProstaLund AB.

ProstaLund AB Daily Chande Momentum Oscillator (CMO) ChartProstaLund AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ProstaLund AB.

ProstaLund AB Daily Williams %R ChartProstaLund AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ProstaLund AB.

ProstaLund AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ProstaLund AB.

ProstaLund AB Daily Average True Range (ATR) ChartProstaLund AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ProstaLund AB.

ProstaLund AB Daily On-Balance Volume (OBV) ChartProstaLund AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ProstaLund AB.

ProstaLund AB Daily Money Flow Index (MFI) ChartProstaLund AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ProstaLund AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

ProstaLund AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ProstaLund AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose9.500
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Prostalund with someone you think should read this too:
  • Are you bullish or bearish on Prostalund? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Prostalund? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ProstaLund AB

I send you an email if I find something interesting about ProstaLund AB.


Comments

How you think about this?

Leave a comment

Stay informed about ProstaLund AB.

Receive notifications about ProstaLund AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.